Exelixis (NASDAQ:EXEL – Get Free Report) had its price target hoisted by equities research analysts at Royal Bank of Canada from $26.00 to $28.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price target indicates a potential […]
Exelixis (NASDAQ:EXEL – Get Free Report) had its price target upped by equities researchers at Royal Bank of Canada from $26.00 to $28.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price target points to a potential upside […]
Exelixis (NASDAQ:EXEL – Free Report) had its price target boosted by Stifel Nicolaus from $23.00 to $25.00 in a research report report published on Friday, Benzinga reports. They currently have a hold rating on the biotechnology company’s stock. A number of other analysts have also weighed in on EXEL. BTIG Research initiated coverage on Exelixis […]
Maintenance Repair And Operations (MRO) Market Size, Share, Trends Analysis & Report 2024-2032 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Tealwood Asset Management Inc. trimmed its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.4% in the third quarter, Holdings Channel reports. The fund owned 62,063 shares of the biotechnology company’s stock after selling 1,548 shares during the period. Tealwood Asset Management Inc.’s holdings in Exelixis were worth $1,356,000 as of its […]